AbbVie (ABBV) Q3 2024 Earnings Call Transcript - MSN

AbbVie (ABBV) Q3 2024 Earnings Call Transcript. Story by Motley Fool Transcribing • 1w. AbbVie (NYSE: ABBV) Q3 2024 Earnings Call. Oct 30, 2024, 9:00 a.m. ET. Read More: Earn up to …

CouponFollow Extension

$3
OFF

AbbVie Inc. (NYSE:ABBV) Q3 2024 Earnings Call Transcript - MSN

1 week from now

AbbVie Inc. (NYSE:ABBV) Q3 2024 Earnings Call Transcript October 30, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $3, expectations were $2.92. Operator: Good …

msn.com

$260
OFF

AbbVie Inc (ABBV) Q3 2024 Earnings Call Highlights: Strong …

1 week from now

For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points. AbbVie Inc reported sales that were $260 million above expectations, driven …

yahoo.com

4%
OFF

AbbVie's Q3 2024 Earnings: What To Expect - MSN

1 week from now

For fiscal 2024, analysts expect AbbVie to report an adjusted EPS of $10.84, down 2.4% from $11.11 in fiscal 2023.However, in fiscal 2025, its adjusted EPS is expected to grow 11.6% …

msn.com

$10.67
OFF

AbbVie Reports Third-Quarter 2024 Financial Results | AbbVie

1 week from now

Oct 30, 2024 · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.67 - $10.87 to $10.90 - $10.94, which includes an unfavorable impact of $0.64 per share …

abbvie.com

$104
OFF

Axsome Therapeutics Q3 Earnings: Stay For Near Term Catalysts, …

1 week from now

5 days ago · Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. ... in the shares of ABBV, BMY either ... sell both AX 07 and Ax 05 listen to the conference call …

seekingalpha.com

$10.67
OFF

AbbVie Reports Third-Quarter 2024 Financial Results - PR Newswire

1 week from now

Oct 30, 2024 · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.67 - $10.87 to $10.90 - $10.94, which includes an unfavorable impact of $0.64 per share …

prnewswire.com

FAQs about AbbVie (ABBV) Q3 2024 Earnings Call Transcript - MSN Coupon?

Did AbbVie beat earnings expectations in Q3 2024?

AbbVie Inc. (NYSE:ABBV) Q3 2024 Earnings Call Transcript October 30, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $3, expectations were $2.92. Operator: Good morning, and thank you for standing by. Welcome to the AbbVie Third Quarter 2024 Earnings Conference Call. ...

When does AbbVie Inc (abbv) release its earnings call?

Release Date: October 30, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. AbbVie Inc (NYSE:ABBV) reported sales that were $260 million above expectations, driven by robust mid-single-digit operational sales growth. ...

When will AbbVie announce its third-quarter 2024 financial results?

NORTH CHICAGO, Ill., Oct. 1, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) will announce its third-quarter 2024 financial results on Wednesday, October 30, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. ...

When will AbbVie release Q3 earnings?

With a market cap of $342.9 billion, AbbVie operates as one of the world’s largest pharma companies. It is expected to release its Q3 earnings before the market opens on Wednesday, Oct. 30. Ahead of the event, analysts expect AbbVie to report a profit of $2.94 per share, marginally down from $2.95 per share reported in the year-ago quarter. ...

How did AbbVie perform in fiscal 2024?

Its adjusted EPS for the last reported quarter declined 8.9% year-over-year to $2.65 but surpassed the consensus estimates by 3.1%. For fiscal 2024, analysts expect AbbVie to report an adjusted EPS of $10.84, down 2.4% from $11.11 in fiscal 2023. However, in fiscal 2025, its adjusted EPS is expected to grow 11.6% year over year to $12.10. ...

What was AbbVie's fourth quarter 2024 earnings guidance?

AbbVie updated its fourth quarter 2024 earnings guidance on Thursday, October, 31st. The company provided EPS guidance of 2.940-2.980 for the period, compared to the consensus earnings per share estimate of 2.950. The company issued revenue guidance of $14.8 billion-$14.8 billion, compared to the consensus revenue estimate of $14.6 billion. ...